SCHEMBL6990099

SCHEMBL6990099

Cc1ccc(S(=O)(=O)N(S(=O)(=O)c2ccc(C)cc2)S(=O)(=O)c2ccc(C)cc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.61
MCOLN3 Q8TDD5 1/20 0.61
GAA P10253 3/20 0.59
C5AR1 P21730 1/20 0.57
AGER Q15109 1/20 0.57
CA12 O43570 2/20 0.55
CA9 Q16790 2/20 0.55
CA1 P00915 2/20 0.54
CA2 P00918 2/20 0.54
CA3 P07451 1/20 0.54
CA6 P23280 1/20 0.54
CA5A P35218 1/20 0.54
CA7 P43166 1/20 0.54
CA5B Q9Y2D0 1/20 0.54
GLA P06280 1/20 0.53
TLR9 Q9NR96 1/20 0.52
ATM Q13315 1/20 0.50
LMNA P02545 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
KEAP1 Q14145 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL82589 0.82 MAPT (0.65) MAPTMCOLN3GAAC5AR1AGER
SCHEMBL26413518 0.82 MAPT (0.65) MAPTMCOLN3GAAC5AR1AGER
SCHEMBL5880406 0.82 MAPT (0.65) MAPTMCOLN3GAAC5AR1AGER
SCHEMBL30082691 0.80 AGER (0.59) MAPTMCOLN3GAAC5AR1AGER
SCHEMBL11335795 0.80 MAPT (0.57) MAPTMCOLN3GAAC5AR1AGER
SCHEMBL24770891 0.80 CA12 (0.62) MAPTMCOLN3GAAC5AR1AGER
Dichloramine-T SCHEMBL151251 0.80 MAPT (0.57) MAPTMCOLN3GAAC5AR1AGER
SCHEMBL30108928 0.80 MAPT (0.57) MAPTMCOLN3GAAC5AR1AGER
SCHEMBL29963641 0.80 APOBEC3G (0.60) MAPTMCOLN3GAAC5AR1AGER
SCHEMBL9811625 0.80 MAPT (0.57) MAPTMCOLN3GAAC5AR1AGER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6589966-B1 A family of hexadentate Fe(II) chelators having marked antiproliferative activity against tumor cells is disclosed. The cytotoxic metal chelators and complexes of the present invention are represented by the general formula below: WAKE FOREST UNIVERSITY HEALTH SCIENCES 2003-07-08 US disclosed
EP-0730616-B1 PROCESS FOR PREPARING POLYAZAMACROCYCLES DOW GLOBAL TECHNOLOGIES INC (US) 2003-02-05 EP disclosed
US-5587451-A Process for preparing polyazamacrocycles THE DOW CHEMICAL COMPANY (US) 1996-12-24 US disclosed
WO-1995014726-A1 PROCESS FOR PREPARING POLYAZAMACROCYCLES THE DOW CHEMICAL COMPANY (US) 1995-06-01 WO disclosed
US-4983376-A Metal complexes BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1991-01-08 US disclosed
US-4001212-A EXTRACT METAL IONS FROM SOLUTION AND COMPLEX E. I. DU PONT DE NEMOURS AND COMPANY (US) 1977-01-04 US disclosed